FXR/Menin-mediated epigenetic regulation of E2F3 expression controls β-cell proliferation and is increased in islets from diabetic GK rats after RYGB
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2024
DOI: 10.1016/j.bbadis.2024.167136 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2024. Verfasst von Xiangchen Kong und 7 weiteren Autor:innen. Beteiligte Einrichtung: Shenzhen University Diabetes Institute, School of Medicine, Shenzhen University, Shenzhen 518060, PR China. Hauptthemen laut MEDLINE: Cell Proliferation, Epigenesis, Genetic, Receptors, Cytoplasmic and Nuclear, Insulin-Secreting Cells. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: University of Pennsylvania, National Natural Science Foundation of China, Foundation for Innovative Research Groups of the National Natural Science Foundation of China.
Abstract (Originalsprache)
Farnesoid X receptor (FXR) improves the function of islets, especially in the setting of Roux-en-Y gastric bypass (RYGB). Here we investigated how FXR activation regulates β-cell proliferation and explored the potential link between FXR signaling and the menin pathway in controlling E2F3 expression, a key transcription factor for controlling adult β-cell proliferation. Stimulation with the FXR agonist GW4064 or chenodeoxycholic acid (CDCA) increased E2F3 expression and β-cell proliferation. Consistently, E2F3 knockdown abolished GW4064-induced proliferation. Treatment with GW4064 increased E2F3 expression in β-cells via enhancing Steroid receptor coactivator-1 (SRC1) recruitment, increasing the pro-transcriptional acetylation of histone H3 at the E2f3 promoter. GW4064 treatment also decreased the association between FXR and menin, leading to the induction of FXR-mediated SRC1 recruitment. Mimicking the impact of FXR agonists, RYGB also increased E2F3 expression and β-cell proliferation in GK rats and SD rats. These findings unravel the crucial role of the FXR/menin signaling in epigenetically controlling E2F3 expression and β-cell proliferation, a mechanism possibly underlying RYGB-induced β-cell proliferation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shenzhen University Diabetes Institute, School of Medicine, Shenzhen University, Shenzhen 518060, PR China.
- Shenzhen University Diabetes Institute, School of Medicine, Shenzhen University, Shenzhen 518060, PR China. Electronic address: xsma@szu.edu.cn.
Förderung
- University of Pennsylvania
- National Natural Science Foundation of China
- Foundation for Innovative Research Groups of the National Natural Science Foundation of China
Zitieren
APA
Kong, X., Yang, C., Li, B., Yan, D., Yang, Y., Cao, C., Xing, B., & Ma, X. (2024). FXR/Menin-mediated epigenetic regulation of E2F3 expression controls β-cell proliferation and is increased in islets from diabetic GK rats after RYGB. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. https://doi.org/10.1016/j.bbadis.2024.167136
Vancouver
Kong X, Yang C, Li B, Yan D, Yang Y, Cao C, et al. FXR/Menin-mediated epigenetic regulation of E2F3 expression controls β-cell proliferation and is increased in islets from diabetic GK rats after RYGB. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2024. doi:10.1016/j.bbadis.2024.167136
BibTeX
@article{Kong2024,
author = {Kong, Xiangchen and Yang, Chenxi and Li, Bingfeng and Yan, Dan and Yang, Yanhui and Cao, Cuihua and Xing, Bowen and Ma, Xiaosong},
title = {FXR/Menin-mediated epigenetic regulation of E2F3 expression controls β-cell proliferation and is increased in islets from diabetic GK rats after RYGB},
journal = {Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease},
year = {2024},
doi = {10.1016/j.bbadis.2024.167136}
}
EUVIMED